Latest News & Updates

Breaking News

  • 8 hours ago

  • Mrudula Kulkarni

CStone Pharmaceuticals Seeks EMA Approval for Sugemalimab in Stage III NSCLC
Breaking News
Merck’s Breakthrough Cardiovascular Research to Take Center Stage at ACC.25

Mrudula Kulkarni

Other trending news you may like to read

Elicio Therapeutics Welcomes Preetam Shah as Chief Strategy and Financial Officer

Elicio appoints Dr. Preetam Shah as CFO to drive financial strategy and accelerate cancer immunotherapy development.

Mrudula Kulkarni

Article

Novo Nordisk Joins Forces with TUL to Advance Breakthrough Obesity and Diabetes Treatment

Novo Nordisk partners with TUL in a $2B deal to develop UBT251, a next-gen therapy for obesity and diabetes.

Mrudula Kulkarni

Article

FDA Supports DBV’s Viaskin Peanut Patch For 4–7-Year-Olds, Eliminating Need For COMFORT Children Study

DBV Technologies secures FDA alignment on Viaskin peanut patch safety data, accelerating BLA submission to H1 2026.

Simantini Singh Deo

Article

Revolutionary AlphaDBS Wins CE Mark, Paving the Way for Smarter Parkinson’s Treatment

Newronika’s AlphaDBS earns CE Mark, introducing real-time adaptive deep brain stimulation for Parkinson’s.

Mrudula Kulkarni

Article